Citable company snapshot
Quest Diagnostics's latest SEC-sourced 2026-06-30 period shows $3.04B in revenue and $320.00M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $3.04B | $2.90B | +5.1% |
| Gross Profit | Dec 31, 2020 | $1.27B | $1.21B | +5.2% |
| Operating Income | Jun 30, 2026 | $459.00M | $399.00M | +15.0% |
| Net Income | Jun 30, 2026 | $320.00M | $252.00M | +27.0% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $597.00M | $278.00M | +114.7% |
| Free Cash Flow (computed) | Jun 30, 2026 | $459.00M | $164.00M | +179.9% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Jul 23, 2026; accession 0001022079-26-000070.
DGX company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.